MedTrace Logo

Study of 15% Versus 30% Velocity Loss Thresholds During Bodyweight Squats and Their Effects on Strength and Endurance in Young Women

NCT07461701 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-03-10

No results posted yet for this study

Summary

The goal of this clinical trial is to learn how two different velocity loss thresholds (15% and 30%) during bodyweight squats affect strength and endurance in non-athletic young women aged 18-25 years.

The main questions it aims to answer are:

Does a lower velocity loss threshold (15%) during bodyweight squats improve lower-limb strength? Does a higher velocity loss threshold (30%) during bodyweight squats improve muscular endurance? Researchers will compare the two groups (15% vs. 30% velocity loss) to see if one approach works better for strength and endurance.

Participants will:

Perform bodyweight squats three times per week for six weeks. Be randomly assigned to either the 15% or 30% velocity loss group. Complete strength and endurance tests before and after the program

Conditions

  • Lower-Limb Strength
  • Muscular Endurance
  • Velocity-Based Resistance Training

Interventions

BEHAVIORAL

Body-weight squat training (15% velocity loss threshold)

Participants will perform supervised body-weight squat training using an intra-set velocity loss threshold of 15%. Velocity loss will be monitored using standardized metronome cadence as a proxy for movement velocity. Training frequency, volume, and progression will be consistent across groups except for the velocity loss threshold.

BEHAVIORAL

Body-weight squat training (30% velocity loss threshold)

Participants will perform supervised body-weight squat training using an intra-set velocity loss threshold of 30%. Velocity loss will be monitored using standardized metronome cadence as a proxy for movement velocity. Training frequency, volume, and progression will be consistent across groups except for the velocity loss threshold.

Sponsors & Collaborators

  • University of Health Sciences Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-22
Primary Completion
2026-04-05
Completion
2026-04-19

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07461701 on ClinicalTrials.gov